{
  "id": "08147b369733b420",
  "title": "FDA : Drug & Device Advisory | Frequentist or Bayesian ? All Roads Lead to Smarter Trials with FDA New Bayesian Guidance | Alston & Bird",
  "description": "20260115T040000Z",
  "content": "",
  "source": "jdsupra.com",
  "source_url": "https://www.jdsupra.com/legalnews/fda-drug-device-advisory-frequentist-or-5413118/",
  "published_at": "20260115T040000Z",
  "fetched_at": "2026-01-16T00:24:08.160649+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.jdsupra.com/legalnews/fda-drug-device-advisory-frequentist-or-5413118/",
    "url_mobile": "",
    "title": "FDA : Drug & Device Advisory | Frequentist or Bayesian ? All Roads Lead to Smarter Trials with FDA New Bayesian Guidance | Alston & Bird",
    "seendate": "20260115T040000Z",
    "socialimage": "https://jdsupra-static.s3.amazonaws.com/profile-images/og.15546_5043.jpg",
    "domain": "jdsupra.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}